Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study

References

• TorreLABrayFSiegelRLGlobal cancer statistics, 2012: Global Cancer Statistics, 2012CA Cancer J Clin2015658710825651787
   PubMed Web of Science ®Google Scholar
• CenterMMJemalASmithRAWardEWorldwide variations in colorectal cancerCA Cancer J Clin200959636637819897840
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015: Cancer Statistics in China, 2015CA Cancer J Clin20166611513226808342
   PubMed Web of Science ®Google Scholar
• DennisDLWaringJLPayeurNCosbyCDaudtHMMaking lifestyle changes after colorectal cancer: insights for program developmentCurr Oncol2013206493511
   PubMed Web of Science ®Google Scholar
• DurkoLMalecka-PanasELifestyle Modifications and Colorectal CancerCurr Colorectal Cancer Rep201410455424659930
   PubMedGoogle Scholar
• GeogheganJGScheeleJTreatment of colorectal liver metastasesBr J Surg199986215816910100781
   PubMed Web of Science ®Google Scholar
• McloughlinJMJensenEHMalafaMResection of colorectal liver metastases: current perspectivesCancer Control2006131324116508624
   PubMedGoogle Scholar
• PawlikTMScogginsCRZorziDEffect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastasesAnn Surg2005241571572415849507
   PubMed Web of Science ®Google Scholar
• ChotiMASitzmannJVTiburiMFTrends in long-term survival following liver resection for hepatic colorectal metastasesAnn Surg2002235675976612035031
   PubMed Web of Science ®Google Scholar
• ScheeleJStanglRAltendorf-HofmannAHepatic metastases from colorectal carcinoma: impact of surgical resection on the natural historyBr J Surg19907711124112462253003
   PubMed Web of Science ®Google Scholar
• AbdallaEKVautheyJNEllisLMRecurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasesAnn Surg2004239681882715166961
   PubMed Web of Science ®Google Scholar
• FelibertiECWagmanLDRadiofrequency ablation of liver metastases from colorectal carcinomaCancer Control2006131485116508626
   PubMedGoogle Scholar
• NordlingerBQuilichiniMAParcRHepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patientsAnn Surg198720532562633827361
   PubMed Web of Science ®Google Scholar
• BozzettiFDociRBignamiPMorabitoAGennariLPatterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approachAnn Surg198720532642703827362
   PubMed Web of Science ®Google Scholar
• de GramontAFigerASeymourMLeucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ Clin Oncol200018162938294710944126
   PubMed Web of Science ®Google Scholar
• TournigandCAndréTAchilleEFOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyJ Clin Oncol200422222923714657227
   PubMed Web of Science ®Google Scholar
• SaltzLBCoxJVBlankeCIrinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study GroupN Engl J Med20003431390591411006366
   PubMed Web of Science ®Google Scholar
• DouillardJYCunninghamDRothADIrinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialLancet200035592091041104710744089
   PubMed Web of Science ®Google Scholar
• EngCShalanNBiological agents versus chemotherapy in the treatment of colorectal cancerExpert Opin Pharmacother20067101251127116805714
   PubMedGoogle Scholar
• AzvolinskyAColorectal cancer: to stack or sequence therapy?J Natl Cancer Inst20151075djv138djv13825957442
   PubMedGoogle Scholar
• FolprechtGGruenbergerTBechsteinWSurvival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)Ann Oncol20142551018102524585720
   PubMed Web of Science ®Google Scholar
• KhanAZMorris-StiffGMakuuchiMPatterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastasesJ Hepatobiliary Pancreat Surg200916213714419093069
   PubMedGoogle Scholar
• ShiinaSTerataniTObiSNonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and per-cutaneous microwave coagulation therapy to radiofrequency ablationOncology200262Suppl 1646811868788
   PubMedGoogle Scholar
• OkadaSLocal ablation therapy for hepatocellular carcinomaSemin Liver Dis199919332332810518311
   PubMed Web of Science ®Google Scholar
• BartolozziCLencioniREthanol injection for the treatment of hepatic tumoursEur Radiol1996656826968934135
   PubMed Web of Science ®Google Scholar
• LeeMJMuellerPRDawsonSLPercutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacyAJR Am J Roentgenol199516412152207998542
   PubMed Web of Science ®Google Scholar
• LivraghiTGoldbergSNLazzaroniSSmall hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injectionRadiology1999210365566110207464
   PubMed Web of Science ®Google Scholar
• MinamiYKudoMRadiofrequency ablation of hepatocellular carcinoma: Current statusWorld J Radiol201021141721179308
   PubMedGoogle Scholar
• RhimHLimHKRadiofrequency ablation of hepatocellular carcinoma: pros and consGut Liver20104Suppl 1S11321103289
   PubMedGoogle Scholar
• GillamsARLeesWRFive-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablationEur Radiol20091951206121319137310
   PubMed Web of Science ®Google Scholar
• GwakJHOhBYLeeRAChungSSKimKHClinical applications of radio-frequency ablation in liver metastasis of colorectal cancerJ Korean Soc Coloproctol201127420221980591
   PubMedGoogle Scholar
• van TilborgAAMeijerinkMRSietsesCLong-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative interventionBr J Radiol201184100255656521159807
   PubMed Web of Science ®Google Scholar
• JakobsTFHoffmannRTTrummCReiserMFHelmbergerTKRadio-frequency ablation of colorectal liver metastases: mid-term results in 68 patientsAnticancer Res2006261B67168016739337
   PubMed Web of Science ®Google Scholar
• van DuijnhovenFHJansenMCJunggeburtJMFactors influencing the local failure rate of radiofrequency ablation of colorectal liver metastasesAnn Surg Oncol200613565165816538411
   PubMed Web of Science ®Google Scholar
• BoameNGreshamGJonkerDUse of chemotherapy and radio-frequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 yearsCurr Oncol2014214557
   Web of Science ®Google Scholar
• SolbiatiLAhmedMCovaLSmall liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-upRadiology2012265395896823091175
   PubMed Web of Science ®Google Scholar
• WatanabeAYangCCheungWYECOG performance status as a predictor of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patientsJ Clin Oncol2017354 Suppl789789
   Web of Science ®Google Scholar
• FernandezFGDrebinJALinehanDCDehdashtiFSiegelBAStrasbergSMFive-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)Ann Surg2004240343845015319715
   PubMed Web of Science ®Google Scholar
• SolbiatiLAhmedMCovaLIeraceTBrioschiMGoldbergSNSmall liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-upRadiology2012265395896823091175
   PubMed Web of Science ®Google Scholar
• BoameNGreshamGJonkerDUse of chemotherapy and radio-frequency ablation to treat colorectal cancer metastases: a retrospective review of The Ottawa Hospital Cancer Centre over 7 yearsCurr Oncol2014214557
   Web of Science ®Google Scholar
• BilchikAJWoodTFAllegraDCryosurgical ablation and radio-frequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithmArch Surg2000135665766210843361
   PubMedGoogle Scholar
• MericFPattYZCurleySASurgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapyAnn Surg Oncol20007749049510947016
   PubMed Web of Science ®Google Scholar
• McgahanJPBrockJMTeslukHGuWZSchneiderPBrowningPDHepatic ablation with use of radio-frequency electrocautery in the animal modelJ Vasc Interv Radiol1992322912971627876
   PubMedGoogle Scholar
• BuscariniESavoiaABrambillaGRadiofrequency thermal ablation of liver tumorsEur Radiol200515588489415754165
   PubMed Web of Science ®Google Scholar
• KuvshinoffBWOtaDMRadiofrequency ablation of liver tumors: influence of technique and tumor sizeSurgery2002132460561212407343
   PubMed Web of Science ®Google Scholar
• SolbiatiLLivraghiTGoldbergSNPercutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patientsRadiology2001221115916611568334
   PubMed Web of Science ®Google Scholar
• OshowoAGillamsAHarrisonELeesWRTaylorIComparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastasesBr J Surg200390101240124314515293
   PubMed Web of Science ®Google Scholar
• LivraghiTSolbiatiLMeloniFIeraceTGoldbergSNGazelleGSPercutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”Cancer200397123027303512784338
   PubMed Web of Science ®Google Scholar
• AloiaTAVautheyJNLoyerEMSolitary colorectal liver metastasis: resection determines outcomeArch Surg2006141546046616702517
   PubMedGoogle Scholar
• LeblancFFonckMBrunetRBecouarnYMathoulin-PélissierSEvrardSComparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastasesEur J Surg Oncol200834218519017998155
   PubMed Web of Science ®Google Scholar
• KimKHYoonYSYuCSCsYComparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastasesJ Korean Surg Soc20118112522066097
   PubMedGoogle Scholar
• HurHKoYTMinBSComparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastasesAm J Surg2009197672873618789428
   PubMed Web of Science ®Google Scholar
• ZhaiZGuJInfluence of tumor size on the prognosis in patients with colon cancerZhonghua Wei Chang Wai Ke Za Zhi Chin J Gastrointest Surg201215495498
   PubMedGoogle Scholar
• ChenCHHsiehMCHsiaoPKLinEKLuYJWuSYA critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinomaJ Cancer20178101927193428819391
   PubMed Web of Science ®Google Scholar
• van DuijnhovenFHJansenMCJunggeburtJMFactors influencing the local failure rate of radiofrequency ablation of colorectal liver metastasesAnn Surg Oncol200613565165816538411
   PubMed Web of Science ®Google Scholar
• NordlingerBSorbyeHGlimeliusBPerioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialLancet200837196171007101618358928
   PubMed Web of Science ®Google Scholar
• GillamsARLeesWRFive-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastasesJ Vasc Interv Radiol200819571271718440460
   PubMed Web of Science ®Google Scholar
• MachiJOishiAJSumidaKLong-term outcome of radio-frequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line managementCancer J200612431832616925977
   PubMed Web of Science ®Google Scholar
• RuersTPuntCVan CoevordenFEORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG)Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)Ann Oncol201223102619262622431703
   PubMed Web of Science ®Google Scholar
• KnudsenARKannerupASMortensenFVNielsenDTRadiofrequency ablation of colorectal liver metastases downstaged by chemotherapyActa Radiol200950771672119488894
   PubMed Web of Science ®Google Scholar
• GillamsARLeesWRSurvival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancerDis Colon Rectum200043565666110826427
   PubMed Web of Science ®Google Scholar
• AbdallaEKVautheyJNEllisLMRecurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasesAnn Surg2004239681882715166961
   PubMed Web of Science ®Google Scholar
• TricoliJVBlairDGAndersCKBiologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaCancer201612271017102826849082
   PubMed Web of Science ®Google Scholar
• BleyerABarrRHayes-LattinBBiology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult OncologyThe distinctive biology of cancer in adolescents and young adultsNat Rev Cancer20088428829818354417
   PubMed Web of Science ®Google Scholar
• HubbardJMGrotheyAAdolescent and young adult colorectal cancerJ Natl Compr Canc Netw201311101219122524142823
   PubMed Web of Science ®Google Scholar